MedPath

Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)

Phase 2
Completed
Conditions
Nonalcoholic Steatohepatitis
Interventions
Registration Number
NCT04971785
Lead Sponsor
Gilead Sciences
Brief Summary

The goals of this clinical study are to learn more about the study drugs, semaglutide (SEMA) with the fixed-dose combination (FDC) of cilofexor/firsocostat (CILO/FIR), and understand whether they cause fibrosis improvement and Nonalcoholic Steatohepatitis (NASH) resolution in participants with cirrhosis due to NASH.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
457
Inclusion Criteria
  • Liver biopsy consistent with cirrhosis (F4) due to nonalcoholic steatohepatitis (NASH) in the opinion of the central reader. In individuals who have never had a liver biopsy, a screening liver biopsy may be performed.

  • Screening laboratory parameters as determined by the study central laboratory:

    • Estimated glomerular filtration rate (eGFR) ≥ 30 mL/min/1.73m^2, as calculated by the Modification of Diet in Renal Disease (MDRD) equation.
    • HbA1c ≤ 10%
    • International normalized ratio (INR) ≤ 1.4, unless due to therapeutic anticoagulation
    • Platelet count ≥ 125,000/uL
    • Alanine aminotransferase (ALT) < 5 x ULN
    • Serum albumin ≥ 3.5 g/dL
    • Serum alkaline phosphatase (ALP) ≤ 2 x ULN
  • Body mass index (BMI) ≥ 23 kg/m^2 at screening.

Key

Exclusion Criteria
  • Prior history of decompensated liver disease, including ascites, hepatic encephalopathy (HE), or variceal bleeding.

  • Child-Pugh (CP) score > 6 at screening, unless due to an alternative etiology such as Gilbert's syndrome or therapeutic anticoagulation.

  • Model for End-stage Liver Disease (MELD) score > 12 at screening, unless due to an alternative etiology such as therapeutic anticoagulation.

  • Other causes of liver disease based on medical history and/or central reader review of liver histology, including but not limited to: alcoholic liver disease, autoimmune disorders (eg, primary biliary cholangitis, primary sclerosing cholangitis, autoimmune hepatitis), drug-induced hepatotoxicity, Wilson disease, clinically significant iron overload, or alpha-1-antitrypsin deficiency.

  • Chronic hepatitis B virus (HBV) infection (HBsAg positive), or Chronic hepatitis C virus (HCV) infection (HCV antibody and HCV ribonucleic acid (RNA) positive). Individuals cured of HCV infection less than 2 years prior to the screening visit are not eligible.

  • History of liver transplantation.

  • Current or prior history of hepatocellular carcinoma (HCC).

  • Men who habitually drink greater than 21 units/week of alcohol or women who habitually drink greater than 14 units/week of alcohol (1 unit is equivalent to 12 ounce (oz)/360 mL of beer, a 4 oz/120 mL glass of wine, or 1 oz/30 mL of hard liquor).

    • For individuals on vitamin E regimen ≥ 800 IU/day, or pioglitazone, dose must be stable, in the opinion of the investigator for at least 180 days prior to the historical or screening liver biopsy.
    • For individuals on medications for diabetes, dose must be stable, in the opinion of the investigator, for at least 90 days prior to the historical or screening liver biopsy.
  • History of type 1 diabetes.

  • Treatment with a glucagon-like peptide-1 receptor agonist (GLP-1 RA) in the period from 90 days prior to the screening visit and for individuals with a qualifying historical liver biopsy, for 90 days prior to the date of the historical liver biopsy.

  • For individuals who have not completed a series of an authorized coronavirus disease 2019 (COVID-19) vaccination regimen prior to screening, a positive result for COVID-19 on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reverse transcriptase-polymerase chain reaction (RT-PCR) test.

Note: Other protocol defined Inclusion/Exclusion criteria may apply.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
SEMA + CILO/FIR FDCCilofexor (CILO)/Firsocostat (FIR)Participants will receive semaglutide (SEMA) 0.24-2.4 mg once weekly (dose escalation every 4 weeks) and fixed-dose combination (FDC) of cilofexor and firsocostat (CILO/FIR 30 mg/20 mg) once daily for 72 weeks
PTM SEMA + PTM CILO/FIRPTM SEMAPTM Semaglutide once weekly and PTM CILO/FIR once daily for 72 weeks
SEMA + Placebo-To-Match (PTM) CILO/FIRSemaglutide (SEMA)Participants will receive SEMA 0.24-2.4 mg once weekly (dose escalation every 4 weeks) and PTM CILO/FIR administered once daily for 72 weeks
SEMA + Placebo-To-Match (PTM) CILO/FIRPTM CILO/FIRParticipants will receive SEMA 0.24-2.4 mg once weekly (dose escalation every 4 weeks) and PTM CILO/FIR administered once daily for 72 weeks
SEMA + CILO/FIR FDCSemaglutide (SEMA)Participants will receive semaglutide (SEMA) 0.24-2.4 mg once weekly (dose escalation every 4 weeks) and fixed-dose combination (FDC) of cilofexor and firsocostat (CILO/FIR 30 mg/20 mg) once daily for 72 weeks
PTM SEMA + PTM CILO/FIRPTM CILO/FIRPTM Semaglutide once weekly and PTM CILO/FIR once daily for 72 weeks
PTM SEMA + CILO/FIR FDCCilofexor (CILO)/Firsocostat (FIR)PTM Semaglutide once weekly and CILO/FIR 30 mg/20 mg FDC administered once daily for 72 weeks
PTM SEMA + CILO/FIR FDCPTM SEMAPTM Semaglutide once weekly and CILO/FIR 30 mg/20 mg FDC administered once daily for 72 weeks
Primary Outcome Measures
NameTimeMethod
Percentage of Participants Who Achieve ≥ 1-Stage Improvement in Fibrosis According to the NASH Clinical Research Network (CRN) Classification Without Worsening of NASH in Participants Treated With SEMA + CILO/FIR Versus PlaceboWeek 72

Worsening of NASH is defined as a ≥ 1-point increase in hepatocellular ballooning or lobular inflammation.

Secondary Outcome Measures
NameTimeMethod
Percentage of Participants With NASH Resolution In Participants Treated With SEMA+CILO/FIR Versus CILO/FIR AloneWeek 72
Percentage of Participants Who Achieve ≥1-Stage Improvement in Fibrosis (According to the NASH CRN Classification) Without Worsening of NASH in Participants Treated With SEMA+CILO/FIR Versus SEMA AloneWeek 72

Worsening of NASH is defined as a ≥ 1-point increase in hepatocellular ballooning or lobular inflammation.

Percentage of Participants With NASH Resolution in Participants Treated with SEMA+CILO/FIR Versus PlaceboWeek 72

NASH resolution is defined as lobular inflammation of 0 or 1 and hepatocellular ballooning of 0.

Trial Locations

Locations (229)

Charter Research

🇺🇸

Winter Park, Florida, United States

Mercy Medical Center

🇺🇸

Baltimore, Maryland, United States

Rush University Medical Group - Department of Hepatology

🇺🇸

Chicago, Illinois, United States

VA Caribbean Healthcare System

🇵🇷

San Juan, Puerto Rico

Sierra Clinical Research

🇺🇸

Las Vegas, Nevada, United States

Schiff Center for Liver Diseases/ University of Miami

🇺🇸

Miami, Florida, United States

ProLive Medical Research, Corp

🇺🇸

Miami, Florida, United States

Liver Specialists of Texas

🇺🇸

Houston, Texas, United States

Houston Research Institute

🇺🇸

Houston, Texas, United States

Precision Research Institute

🇺🇸

San Diego, California, United States

Medical Associates Research Group

🇺🇸

San Diego, California, United States

Quest Clinical Research

🇺🇸

San Francisco, California, United States

University of California, San Francisco - Liver Clinic

🇺🇸

San Francisco, California, United States

American Research Corporation at the Texas Liver Institute

🇺🇸

San Antonio, Texas, United States

Diabetes and Glandular Disease Clinic, P.A.

🇺🇸

San Antonio, Texas, United States

Pinnacle Clinical Research, LLC

🇺🇸

San Antonio, Texas, United States

University of Utah Hospital

🇺🇸

Salt Lake City, Utah, United States

Henry Ford Health System

🇺🇸

Detroit, Michigan, United States

The Institution For Liver Health dba Arizona Liver Health

🇺🇸

Tucson, Arizona, United States

Kaiser Permanente Los Angeles Medical Center

🇺🇸

Los Angeles, California, United States

University of California, San Diego - Altman Clinical and Translational Research Institute

🇺🇸

La Jolla, California, United States

Adobe Clinical Research, LLC

🇺🇸

Tucson, Arizona, United States

Knowledge Research Center

🇺🇸

Orange, California, United States

Cadena Care Institute, LLC

🇺🇸

Poway, California, United States

Research and Education Inc.

🇺🇸

San Diego, California, United States

Biopharma Informatic, LLC

🇺🇸

McAllen, Texas, United States

Southwest General Healthcare Center

🇺🇸

Fort Myers, Florida, United States

Indago Research and Health Center, Inc.

🇺🇸

Hialeah, Florida, United States

TriWest Research Associates, LLC

🇺🇸

San Diego, California, United States

United Medical Doctors

🇺🇸

Murrieta, California, United States

Encore Borland-Groover Clinical Research

🇺🇸

Jacksonville, Florida, United States

Evolution Clinical Research, INC

🇺🇸

Hialeah Gardens, Florida, United States

Synergy Healthcare

🇺🇸

Bradenton, Florida, United States

Hawthorn Medical Associates

🇺🇸

South Dartmouth, Massachusetts, United States

Covenant Metabolic Specialists, LLC

🇺🇸

Sarasota, Florida, United States

Ocean Blue Medical Research Center, Inc

🇺🇸

Miami Springs, Florida, United States

Gastroenterology Group of Naples

🇺🇸

Naples, Florida, United States

New Generation of Medical Research

🇺🇸

Hialeah, Florida, United States

Florida Medical Clinic, LLC

🇺🇸

Zephyrhills, Florida, United States

UF Health Jacksonville-Gastroenterology Emerson

🇺🇸

Jacksonville, Florida, United States

Sunbright Health Medical Center

🇺🇸

Homestead, Florida, United States

Advanced Pharma CR, LLC

🇺🇸

Miami, Florida, United States

Century Research, LLC

🇺🇸

Miami, Florida, United States

Ocala GI Research

🇺🇸

Ocala, Florida, United States

Kansas Medical Clinic PA

🇺🇸

Topeka, Kansas, United States

Beth Israel Deaconess Medical Center

🇺🇸

Boston, Massachusetts, United States

New York University Langone Health

🇺🇸

New York, New York, United States

Northwell Health Center for Liver Diseases

🇺🇸

Manhasset, New York, United States

Internal Medicine Digestive and Liver Diseases Clinical Trials

🇺🇸

Dallas, Texas, United States

University of Pittsburgh Medical Center

🇺🇸

Pittsburgh, Pennsylvania, United States

Velocity Clinical Research - Providence

🇺🇸

East Greenwich, Rhode Island, United States

South Texas Research Institute

🇺🇸

Edinburg, Texas, United States

Digestive Health Research of North Texas

🇺🇸

Wichita Falls, Texas, United States

Intermountain Medical Center

🇺🇸

Murray, Utah, United States

Virginia Mason

🇺🇸

Seattle, Washington, United States

The University Of Vermont Medical Center

🇺🇸

Burlington, Vermont, United States

Monash Health, Monash Medical Centre (Clayton)

🇦🇺

Clayton, Victoria, Australia

Centre Hospitalier Universitaire Limoges

🇫🇷

Limoges, France

Centre de Recherche du Centre Hospitalier de I'Universite de Montreal (CRCHUM)

🇨🇦

Montreal, Canada

Liver Institute Northwest

🇺🇸

Seattle, Washington, United States

Flinders Medical Centre

🇦🇺

Adelaide, South Australia, Australia

McMaster University Medical Center

🇨🇦

Hamilton, Canada

Centre Hospitalier Regional Universitaire de Tours - Hopital Trousseau

🇫🇷

Chambray-les-Tours, France

Royal Brisbane and Women's Hospital

🇦🇺

Herston, Queensland, Australia

Toronto Digestive Disease Associates Specialty Research

🇨🇦

Vanghan, Canada

Westmead Hospital

🇦🇺

Westmead, New South Wales, Australia

Eastern Health, Box Hill Hospital

🇦🇺

Box Hill, Victoria, Australia

Digestive and Liver Disease Specialists

🇺🇸

Norfolk, Virginia, United States

London Health Sciences Centre - University Hospital

🇨🇦

London, Canada

Toronto Liver Centre

🇨🇦

Toronto, Canada

CHU Amiens Picardie

🇫🇷

Amiens, France

Wlliam Osler Health System - Brampton Civic Hospital

🇨🇦

Brampton, Canada

Fukui-ken Saiseikai Hospital

🇯🇵

Fukui, Japan

Japanese Red Cross Masashino Hospital

🇯🇵

Musashino-city, Japan

Hopitaux de Paris - Hopital Cochin

🇫🇷

Paris, France

FDI Clinical Research

🇵🇷

San Juan, Puerto Rico

Hospital Germans Trias i Pujol

🇪🇸

Badalona, Barcelona, Spain

Ehime University Hospital

🇯🇵

Toon-Shi, Japan

Hospital General Universiatrio Gregorio Maranon

🇪🇸

Madrid, Spain

Hospital Universitario Puerta de Hierro-Majadahonda

🇪🇸

Majadahonda, Spain

Hospital del Mar

🇪🇸

Barcelona, Spain

Hospital Universitario Marques de Valdecilla

🇪🇸

Santander, Spain

Hospital Clinico Universitario de Santiago

🇪🇸

Santiago De Compostella, Spain

Hospital Universitario Virgin del Rocio

🇪🇸

Sevilla, Spain

University of Alabama at Birmingham Hospital

🇺🇸

Birmingham, Alabama, United States

Mayo Clinic

🇺🇸

Rochester, Minnesota, United States

Toronto General Hospital - University Health Network

🇨🇦

Toronto, Canada

(G.I.R.I.) Gastrointestinal Research Institute

🇨🇦

Vancouver, Canada

Centre Hospitalier Universitaire de Nice - Hopital L'archet

🇫🇷

Nice, France

Hopital Brabois Adultes - CHU de Nancy

🇫🇷

Vandoeuvre les Nancy, France

Saga University Hospital

🇯🇵

Saga-shi, Japan

Saiseikai Suita Hospital

🇯🇵

Suita, Japan

Yokohama City University Hospital

🇯🇵

Yokohama-shi, Japan

Complejo Hospitalario de Pontevedra

🇪🇸

Pontevedra, Spain

Velocity Clinical Research, Salt Lake City

🇺🇸

West Jordan, Utah, United States

University of Colorado Anschutz Medical Campus

🇺🇸

Aurora, Colorado, United States

Walter Reed National Military Medical Center

🇺🇸

Bethesda, Maryland, United States

Keck Medical Center of USC Healthcare Consultation II

🇺🇸

Los Angeles, California, United States

California Liver Research Institute

🇺🇸

Pasadena, California, United States

Palmtree Clinical Research, Inc.

🇺🇸

Palm Springs, California, United States

Gastrointestinal (GI) Specialists of Georgia

🇺🇸

Marietta, Georgia, United States

Iowa Digestive Disease Center, PC

🇺🇸

Clive, Iowa, United States

CHU de Grenoble

🇫🇷

Grenoble Cedex 9, France

Velocity Clinical Research, Hallandale Beach

🇺🇸

Hallandale Beach, Florida, United States

San Jose Gastroenterology at One Health

🇺🇸

San Jose, California, United States

Southeast Clinical Research LLC

🇺🇸

Dalton, Georgia, United States

G+C Research Group

🇺🇸

Miami, Florida, United States

Advanced Medical Research Center

🇺🇸

Port Orange, Florida, United States

Allied Health Clinical Research Organization, LLC

🇺🇸

Freehold, New Jersey, United States

Digestive Research Alliance of Michigan

🇺🇸

South Bend, Indiana, United States

Royal Perth Hospital

🇦🇺

Perth, Western Australia, Australia

Centre Hosptitalier Universitaire d'Angers

🇫🇷

Angers, France

Hopital Saint Joseph

🇫🇷

Marseille, France

Sapporo-Kosei General Hospital

🇯🇵

Sapporo-shi, Japan

Hopital Universitaire Pitie Salpetriere

🇫🇷

Paris, France

Yamagata University Hospital

🇯🇵

Yamagata, Japan

University Hospital, Kyoto Prefectural University of Medicine

🇯🇵

Kyoto, Japan

Digestive Health Specialists

🇺🇸

Dothan, Alabama, United States

Arizona Health Research

🇺🇸

Chandler, Arizona, United States

The Institute for Liver Health DBA Arizona Liver Health

🇺🇸

Peoria, Arizona, United States

Gastrointestinal Alliance - Sun City

🇺🇸

Sun City, Arizona, United States

Arkansas Diagnostic Center

🇺🇸

Little Rock, Arkansas, United States

ARCare Center for Clinical Research

🇺🇸

Little Rock, Arkansas, United States

Arkansas Gastroenterology

🇺🇸

North Little Rock, Arkansas, United States

University of California, San Francisco - Fresno

🇺🇸

Fresno, California, United States

Inland Empire Clinical Trials

🇺🇸

Rialto, California, United States

Digestive Health Research of Southern California

🇺🇸

Long Beach, California, United States

Gastro Care Institute (Fibroscan)

🇺🇸

Lancaster, California, United States

Southern California Research Center

🇺🇸

Coronado, California, United States

Stanford Medicine Outpatient Center

🇺🇸

Redwood City, California, United States

Nature Coast Clinical Research

🇺🇸

Inverness, Florida, United States

Excel Medical Clinical Trials, LLC

🇺🇸

Boca Raton, Florida, United States

South Denver Gastroenterology

🇺🇸

Englewood, Colorado, United States

Maya Research Center

🇺🇸

Hialeah, Florida, United States

Florida Research Institute

🇺🇸

Lakewood Ranch, Florida, United States

Advanced Research Institute, Inc.

🇺🇸

New Port Richey, Florida, United States

International Medical Investigational Centers, Inc.

🇺🇸

Miami, Florida, United States

Progressive Medical Research

🇺🇸

Port Orange, Florida, United States

Indiana University Health Enterprise Clinical Research Operations

🇺🇸

Indianapolis, Indiana, United States

Gastroenterology Health Partners, PLLC

🇺🇸

New Albany, Indiana, United States

University of Iowa Hospitals and Clinics

🇺🇸

Iowa City, Iowa, United States

GI Alliance

🇺🇸

Webster, Texas, United States

Combined Gastro Research, LLC

🇺🇸

Lafayette, Louisiana, United States

Delta Research Partners

🇺🇸

Monroe, Louisiana, United States

Louisiana Research Center, LLC

🇺🇸

Shreveport, Louisiana, United States

Greater Boston Gastroenterology

🇺🇸

Framingham, Massachusetts, United States

Woodholme Gastroenterology Associates

🇺🇸

Glen Burnie, Maryland, United States

Clinical Research Institute of Michigan, LLC

🇺🇸

Chesterfield, Michigan, United States

Gastroenterology Associates of Western Michigan, PLC d.b.a. West Michigan Clinical Research Center

🇺🇸

Wyoming, Michigan, United States

Huron Gastroenterology Associates

🇺🇸

Ypsilanti, Michigan, United States

Digestive Disease Research

🇺🇸

Florham Park, New Jersey, United States

Clinical Research Professionals

🇺🇸

Chesterfield, Missouri, United States

Southern Therapy and Advanced Research

🇺🇸

Jackson, Mississippi, United States

GI Associates Research

🇺🇸

Columbia, Missouri, United States

Rutgers New Jersey Medical School

🇺🇸

Newark, New Jersey, United States

Mount Sinai Medical Center

🇺🇸

New York, New York, United States

Liver Clinic (study visits, Fibroscan): Columbia University Irving Medical Center / NewYork Presbyterian Hospital

🇺🇸

New York, New York, United States

The New York - Presbyterian Hospital

🇺🇸

New York, New York, United States

Asheville Gastroenterology, a Division of Digestive Health Partners, PA

🇺🇸

Asheville, North Carolina, United States

Atrium Health Transplant and Center for Liver Disease

🇺🇸

Charlotte, North Carolina, United States

Coastal Research Institute

🇺🇸

Fayetteville, North Carolina, United States

Charlotte Gastroenterology & Hepatology, PLLC

🇺🇸

Charlotte, North Carolina, United States

Lucas Research, Inc.

🇺🇸

Morehead City, North Carolina, United States

Carolina's GI Research, LLC

🇺🇸

Raleigh, North Carolina, United States

Optimed Research

🇺🇸

Columbus, Ohio, United States

DSI Research

🇺🇸

Springboro, Ohio, United States

Options Health Research, LLC

🇺🇸

Tulsa, Oklahoma, United States

Clinical Research Institute of Ohio, LLC

🇺🇸

Westlake, Ohio, United States

University Gastroenterology

🇺🇸

Providence, Rhode Island, United States

Columbia Digestive Health Research

🇺🇸

Columbia, South Carolina, United States

Velocity Clinical Research, Spartanburg

🇺🇸

Spartanburg, South Carolina, United States

Digestive Disease Research Center

🇺🇸

Greenwood, South Carolina, United States

Wake Research - ClinsSearch, LLC

🇺🇸

Chattanooga, Tennessee, United States

Gastrointestinal Associates of Northeast Tennessee

🇺🇸

Johnson City, Tennessee, United States

Texas Clinical Research Institute

🇺🇸

Arlington, Texas, United States

Pinnacle Clinical Research

🇺🇸

Georgetown, Texas, United States

Quality Medical Research, PLLC

🇺🇸

Nashville, Tennessee, United States

The Liver Institute at Methodist Dallas Medical Center

🇺🇸

Dallas, Texas, United States

Soma Clinical Trials, LLC

🇺🇸

Denison, Texas, United States

Houston Methodist Hospital

🇺🇸

Houston, Texas, United States

DHR Health Institute for Research and Development Cancer Research Center

🇺🇸

Edinburg, Texas, United States

Texas Digestive Specialists

🇺🇸

Harlingen, Texas, United States

Liver Associates of Texas, P.A.

🇺🇸

Houston, Texas, United States

Impact Research Institute

🇺🇸

Waco, Texas, United States

BioStar Clinical Research Group Inc.

🇺🇸

Katy, Texas, United States

Digestive System Healthcare

🇺🇸

Pasadena, Texas, United States

University of Virginia Medical Center

🇺🇸

Charlottesville, Virginia, United States

Manassas Clinical Research Center

🇺🇸

Manassas, Virginia, United States

Liverpool Hospital

🇦🇺

Liverpool, New South Wales, Australia

University of Calgary Liver Unit - Heritage Medical Research Clinic

🇨🇦

Calgary, Canada

Chronic Viral Illness Service, Royal Victoria Hospital, McGill University Health Centre (MUHC)

🇨🇦

Montreal, Canada

Gordon and Leslie Diamond Health Care Centre, Vancouver General Hospital, UBC Division of Gastroenterology

🇨🇦

Vancouver, Canada

Hopital Beaujon

🇫🇷

Pessac, France

Hopital Henri Mondor

🇫🇷

Creteil, France

Hopital Claude Huriez

🇫🇷

Lille Cedex, France

Hopital Rangueil

🇫🇷

Toulouse, France

Hopital de la Croix-Rousse

🇫🇷

Lyon, France

CHU Rennes Pontchaillou

🇫🇷

Rennes, France

Centre Hospitalier Universitarie de Montpellier - Hospital Saint-Eloi

🇫🇷

Montpellier, France

Juntendo University Shizouka Hospital

🇯🇵

Izunokuni, Japan

Osaka City University Hospital

🇯🇵

Osaka, Japan

Federation of National Public Service Personnel Mutual Aid Associations Toranomon Hospital

🇯🇵

Tokyo, Japan

Latin Clinical Trial Center

🇵🇷

San Juan, Puerto Rico

Hospital Universitario Torrecardenas

🇪🇸

Almeria, Spain

Hospital Universitario Ramon y Cajal

🇪🇸

Madrid, Spain

Hospital Clinic De Barcelona

🇪🇸

Barcelona, Spain

Hospital Universitari Vall d'Hebron

🇪🇸

Barcelona, Spain

Hospital Universitario La Paz Edificio de Malemidad

🇪🇸

Madrid, Spain

Consorcio Hospital General Universitario de Valencia

🇪🇸

Valencia, Spain

Hospital Universitario y Politecnlo la Fe

🇪🇸

Valencia, Spain

Hospital Clinico Universitario de Valladolid

🇪🇸

Valladolid, Spain

Tandem Clinical Research GI, LLC

🇺🇸

Marrero, Louisiana, United States

North Alabama Health Research, LLC

🇺🇸

Madison, Alabama, United States

GI Alliance (Patients Seen, IP Shipment & Fibroscan)

🇺🇸

San Marcos, Texas, United States

Northeast GI Research Division

🇺🇸

Concord, North Carolina, United States

Hopital Haut Leveque

🇫🇷

Pessac Cedex, France

University of California, Davis Medical Center

🇺🇸

Sacramento, California, United States

Yale Center for Clinical Investigation, Church Street Research Unit

🇺🇸

New Haven, Connecticut, United States

Michigan Medicine - University of Michigan

🇺🇸

Ann Arbor, Michigan, United States

Kansas City Research Institute

🇺🇸

Kansas City, Missouri, United States

Medical University of South Carolina

🇺🇸

Charleston, South Carolina, United States

University of Florida Hepatology Research at the Clinical and Translational Research Building

🇺🇸

Gainesville, Florida, United States

Oschner Clinic Foundation

🇺🇸

New Orleans, Louisiana, United States

Tulane University Health Sciences Center

🇺🇸

New Orleans, Louisiana, United States

Bon Secours Richmond Community Hospital, Inc. d/b/a Bon Secours Liver Institute of Richmond

🇺🇸

Richmond, Virginia, United States

Virginia Commonwealth University Health Clinical Research Services Unit

🇺🇸

Richmond, Virginia, United States

Center for Research at Southwest Gastroenterology Associates, PC

🇺🇸

Albuquerque, New Mexico, United States

University of Rochester Medical Center

🇺🇸

Rochester, New York, United States

University of Kansas Medical Center

🇺🇸

Kansas City, Kansas, United States

© Copyright 2025. All Rights Reserved by MedPath